1. Home
  2. EW vs HLN Comparison

EW vs HLN Comparison

Compare EW & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EW
  • HLN
  • Stock Information
  • Founded
  • EW 1958
  • HLN 2022
  • Country
  • EW United States
  • HLN United Kingdom
  • Employees
  • EW N/A
  • HLN N/A
  • Industry
  • EW Industrial Specialties
  • HLN Package Goods/Cosmetics
  • Sector
  • EW Health Care
  • HLN Consumer Discretionary
  • Exchange
  • EW Nasdaq
  • HLN Nasdaq
  • Market Cap
  • EW 39.3B
  • HLN 47.1B
  • IPO Year
  • EW 2000
  • HLN N/A
  • Fundamental
  • Price
  • EW $70.48
  • HLN $9.65
  • Analyst Decision
  • EW Buy
  • HLN Strong Buy
  • Analyst Count
  • EW 21
  • HLN 2
  • Target Price
  • EW $76.60
  • HLN $10.48
  • AVG Volume (30 Days)
  • EW 5.1M
  • HLN 6.5M
  • Earning Date
  • EW 10-24-2024
  • HLN 08-01-2024
  • Dividend Yield
  • EW N/A
  • HLN 1.63%
  • EPS Growth
  • EW 193.69
  • HLN N/A
  • EPS
  • EW 6.89
  • HLN 0.18
  • Revenue
  • EW $6,314,900,000.00
  • HLN $15,065,004,686.00
  • Revenue This Year
  • EW $0.34
  • HLN $2.92
  • Revenue Next Year
  • EW $1.64
  • HLN $2.80
  • P/E Ratio
  • EW $10.23
  • HLN $26.25
  • Revenue Growth
  • EW 24.02
  • HLN N/A
  • 52 Week Low
  • EW $58.93
  • HLN $7.89
  • 52 Week High
  • EW $96.12
  • HLN $10.80
  • Technical
  • Relative Strength Index (RSI)
  • EW 61.21
  • HLN 48.76
  • Support Level
  • EW $65.31
  • HLN $9.32
  • Resistance Level
  • EW $71.08
  • HLN $9.86
  • Average True Range (ATR)
  • EW 1.80
  • HLN 0.09
  • MACD
  • EW 0.45
  • HLN 0.03
  • Stochastic Oscillator
  • EW 90.23
  • HLN 78.99

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: